Iron-deficiency Clinical Trial
Official title:
Effect of Processing Temperature on Iron Absorption From Iron Fortified Rice in Young Women
Verified date | October 2018 |
Source | Swiss Federal Institute of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Food fortification is regarded as a safe and cost-effective approach to counteract and
prevent iron deficiency. Rice is a staple food for millions of people living in regions where
iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a
promising fortification vehicle.
Hot and cold extrusion, have been identified as the major methods for rice fortification.
Extruded rice has the advantage of incorporating vitamins and minerals into the food matrix.
Cold, warm and hot extrusion differ in the processing temperature and the physical structure
of fortified rice kernel matrix. A recent human study in young women showed fractional iron
absorption was higher in cold extruded rice compared to hot extruded Rice and this was
associated with changes in the starch microstructure. These changes cannot be detected in
warm extruded rice, thus, our aim is to test the iron bioavailability in difference extrusion
methods; hot and warm and cold with and without the solubilizing agent CA/TSC. This will
provide information on optimized rice formulations for optimal iron delivery.
Status | Active, not recruiting |
Enrollment | 22 |
Est. completion date | December 2018 |
Est. primary completion date | December 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Female, 18 to 40 years old - Normal body Mass Index (18.5 - 25 kg/m2) - Body weight = 65 kg - Signed informed consent Exclusion Criteria: - Pregnancy (assessed by self-declaration) - Lactating up to 6 weeks before study initiation - Anaemia (Hb < 12.0 g/dL) - Elevate CRP (>5.0 mg/L) - Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement) - Continuous/long-term use of medication during the whole study (except for contraceptives) - Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal administration - Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months - Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days - Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments) - Smokers (> 1 cigarette per week) - Difficulties with blood sampling - Male gender - Do not understand English |
Country | Name | City | State |
---|---|---|---|
Switzerland | Human Nutrition Laboratory, ETH Zurich | Zürich |
Lead Sponsor | Collaborator |
---|---|
Swiss Federal Institute of Technology |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in the isotopic ratio of iron in blood at week 2 | The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes. | baseline, 2 weeks | |
Primary | Change from week 2 in the isotopic ratio of iron in blood at week 4 | The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes. | 2 weeks, 4 weeks | |
Primary | Change from week 4 in the isotopic ratio of iron in blood at week 6 | The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes. | 4 weeks, 6 weeks | |
Primary | Change from week 6 in the isotopic ratio of iron in blood at week 8 | The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes. | 6 weeks, 8 weeks | |
Primary | Change from week 8 in the isotopic ratio of iron in blood at week 10 | The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes. | 8 weeks, 10 weeks | |
Secondary | Haemoglobin | Haemoglobin of each timepoint | 2, 4,6,8 and 10 weeks | |
Secondary | Plasma Ferritin | Plasma Ferritin of each timepoint | 2, 4, 6, 8 and 10 weeks | |
Secondary | Inflammation marker | Plasma Ferririn of each timepoint | 2, 4, 6, 8 and 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
Terminated |
NCT03218384 -
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
|
Phase 2 | |
Active, not recruiting |
NCT03516734 -
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
|
N/A | |
Completed |
NCT03572010 -
Stable Iron Isotope Method in HIV+ and HIV- Children
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Not yet recruiting |
NCT05395468 -
Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
|
||
Withdrawn |
NCT03800446 -
Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood
|
N/A | |
Not yet recruiting |
NCT03353662 -
Sub Regional Micronutrient Survey in Ethiopia
|
||
Completed |
NCT03819530 -
Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study
|
N/A | |
Recruiting |
NCT04144790 -
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
|
||
Completed |
NCT03957057 -
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
|
Phase 3 | |
Completed |
NCT03642223 -
Central and Peripheral Adiposity and Iron Absorption
|
N/A | |
Not yet recruiting |
NCT05407987 -
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
|
Phase 3 | |
Withdrawn |
NCT03873584 -
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
|
||
Enrolling by invitation |
NCT03897673 -
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas
|
N/A | |
Completed |
NCT04359368 -
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
|
||
Active, not recruiting |
NCT04778072 -
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
|
N/A | |
Enrolling by invitation |
NCT05750940 -
Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
|
||
Recruiting |
NCT05126901 -
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
|
Phase 3 | |
Recruiting |
NCT05609318 -
Imaging Intravenous Iron
|